RAMBALDI, BENEDETTA
 Distribuzione geografica
Continente #
NA - Nord America 690
EU - Europa 235
AS - Asia 130
OC - Oceania 2
AF - Africa 1
Totale 1.058
Nazione #
US - Stati Uniti d'America 685
CN - Cina 83
UA - Ucraina 67
IT - Italia 47
DE - Germania 43
HK - Hong Kong 34
FI - Finlandia 21
IE - Irlanda 18
SE - Svezia 16
BE - Belgio 9
GB - Regno Unito 6
IN - India 6
CA - Canada 5
FR - Francia 4
SG - Singapore 3
AU - Australia 2
GR - Grecia 2
TH - Thailandia 2
JO - Giordania 1
LV - Lettonia 1
RO - Romania 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 1.058
Città #
Fairfield 88
Chandler 63
Jacksonville 54
Ashburn 53
Ann Arbor 48
New York 42
Wilmington 41
Beijing 40
Woodbridge 39
Houston 37
Seattle 37
Princeton 36
Hong Kong 34
Cambridge 30
Helsinki 21
Dublin 18
Shanghai 16
Boardman 11
Des Moines 10
Brescia 9
Brussels 9
Jinan 6
Nanjing 5
Toronto 5
San Diego 4
San Francisco 4
Shenyang 4
Falkenstein 3
Hebei 3
Milan 3
Pune 3
Brooklyn 2
Guangzhou 2
Haikou 2
Leawood 2
Melbourne 2
Mumbai 2
Amman 1
Athens 1
Augusta 1
Bangkok 1
Boston 1
Bucharest 1
Catania 1
Centurion 1
Changsha 1
Chicago 1
Chiswick 1
Darfo 1
Hangzhou 1
Hanover 1
Hillsborough 1
Jiaxing 1
Kocaeli 1
Landshut 1
London 1
Montecatini Terme 1
Nürnberg 1
Orange 1
Porto 1
Redwood City 1
Riga 1
Santa Clara 1
Singapore 1
Tianjin 1
Totale 816
Nome #
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 115
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 97
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 78
"Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study 71
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 65
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 65
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 63
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 55
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 53
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 53
Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line? 53
ANTI-CMV IMMUNOGLOBULINS IN ASSOCIATION WITH ANTI-CMV DRUGS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION: A MULTI-CENTRE RETROSPECTIVE EXPERIENCE 50
Allogeneic transplantation for patient with myelodisplastic sindromes: a single centre experience 49
Incidence and Outcome of Bacterial Blood Stream Infections in Allotransplanted Patients: Rethinking the Role of Fluoroquinolone Prophylaxis 48
EXTRACORPOREAL PHOTOPHERESIS FOR THE TREATEMENT OF ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: A RETROSPECTIVE MULTICENTRIC ANALYSIS ON 94 PATIENTS. 47
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 45
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 41
PS1540 MULTIPARAMETRIC PREDICTIVE SCORE FOR GRAFT VERSUS HOST DISEASE (GVHD) IN PATIENTS SUBMITTED TO ALLOGENEIC STEM CELLS TRANSPLANTATION (SCT) 37
Totale 1.085
Categoria #
all - tutte 6.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.520


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 0 0 5
2019/2020240 10 1 5 17 13 16 13 16 39 63 22 25
2020/2021280 10 16 9 43 13 37 15 35 24 41 21 16
2021/2022173 12 11 3 13 12 20 5 12 7 29 9 40
2022/2023162 24 5 8 8 15 43 0 21 21 2 8 7
2023/2024202 21 5 25 9 8 61 4 5 43 0 3 18
Totale 1.085